RTO

Business Context and Reporting Period

Company: Rentokil Initial plc
Filing Type: Form 6-K (Interim Results)
Reporting Period: Six months ended 30 June 2025 (H1 2025)
Key Context: The Group changed its presentation currency from Sterling to US Dollars effective 1 January 2025. Following the Terminix acquisition, reporting segments are now North America and International. The France Workwear business is classified as a discontinued operation pending sale.

Key Financial Metrics

Note: Statutory Operating Profit was $304m (H1 2024: $380m) and Statutory Profit Before Tax was $216m (H1 2024: $294m), significantly impacted by one-off items.

Material Changes vs. Prior Period

• Revenue Growth: Group revenue grew 3.1% (reported) driven by International growth of 5.1% and North America growth of 2.0%. Organic revenue growth was 1.6% overall.
• Profitability Pressure: Adjusted Operating Profit declined 4.5% primarily due to lower profitability in North America, where volumes decreased despite price realization. North America Adjusted Operating Margin fell to 16.9% from 18.6%.
• One-Off Items: Statutory results were heavily impacted by a $79m increase in the provision for legacy Termite Damage claims and $30m in Terminix integration costs.
• Cash Flow Improvement: Free Cash Flow increased 31.2% to $282m, driven by improved working capital performance (outflow reduced by $64m vs prior year) and lower interest payments.
• Net Debt: Net debt increased to $4,220m, largely due to a c.$175m adverse foreign exchange impact on bond carrying values, despite strong cash generation.

Guidance, Outlook, and Risks

Outlook and Guidance

• Full Year 2025: Management expects FY25 results to be in line with market expectations. Current trading is in line with expectations.
• North America Strategy: Expectations of c.$100m cost reduction and achieving an operating margin above 20% post-2026 remain unchanged, though integration timelines may be refined.
• Dividend: Interim dividend maintained at 4.15 cents per share.
• Capital Expenditure: FY25 Capex guidance revised to c.$210-220m (reduced from $300-310m) following the pending sale of France Workwear.

Key Risks and Contingencies

• Termite Provisions: Legacy termite warranty obligations increased to $276m due to a rise in complex litigation claims and a 9% increase in cost per claim. Sensitivity analysis indicates significant volatility based on claim rates and values.
• Integration Risks: Ongoing integration of Terminix and other bolt-on acquisitions carries execution risk; total one-time integration costs are expected to be c.$350m.
• Disposal of France Workwear: Sale to H.I.G. Capital approved by the European Commission; completion expected in late Q3/early Q4 2025 for c.$420m net cash proceeds.

Investor Verification Checklist

• Termite Provision Sensitivity: Verify the assumptions regarding claim rates and costs per claim, as a 5% change in litigated claim values could impact the provision by c.$5m.
• North America Organic Growth: Confirm the sustainability of the Q2 organic growth improvement (1.4% vs 0.7% in Q1) and the impact of new marketing initiatives on lead flow.
• France Workwear Sale Completion: Monitor the closing of the France Workwear transaction in Q3/Q4 2025 to realize the expected c.$420m cash proceeds and Capex reduction.
• FX Impact on Net Debt: Assess the ongoing impact of USD strength/weakness on the carrying value of EUR and GBP denominated debt.
• Integration Costs: Track the burn rate of the c.$350m total integration costs, specifically the c.$100m expected in 2025-2026.